LU83849A1 - PROCESS FOR THE PREPARATION OF XANTHINE DERIVATIVES - Google Patents
PROCESS FOR THE PREPARATION OF XANTHINE DERIVATIVES Download PDFInfo
- Publication number
- LU83849A1 LU83849A1 LU83849A LU83849A LU83849A1 LU 83849 A1 LU83849 A1 LU 83849A1 LU 83849 A LU83849 A LU 83849A LU 83849 A LU83849 A LU 83849A LU 83849 A1 LU83849 A1 LU 83849A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- methyl
- xanthine
- pharmacologically
- general formula
- tetrahydrofurylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8041247 | 1980-12-23 | ||
| GB8041247 | 1980-12-23 | ||
| GB8121332 | 1981-07-10 | ||
| GB8121332 | 1981-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83849A1 true LU83849A1 (en) | 1982-05-07 |
Family
ID=26277965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83849A LU83849A1 (en) | 1980-12-23 | 1981-12-22 | PROCESS FOR THE PREPARATION OF XANTHINE DERIVATIVES |
Country Status (16)
| Country | Link |
|---|---|
| AR (1) | AR229037A1 (sv) |
| AU (1) | AU7868481A (sv) |
| DE (1) | DE3150550A1 (sv) |
| DK (1) | DK571581A (sv) |
| ES (1) | ES508103A0 (sv) |
| FI (1) | FI814105L (sv) |
| FR (1) | FR2498602A1 (sv) |
| GR (1) | GR76972B (sv) |
| IT (1) | IT1195301B (sv) |
| LU (1) | LU83849A1 (sv) |
| MA (1) | MA19357A1 (sv) |
| NL (1) | NL8105749A (sv) |
| NO (1) | NO814373L (sv) |
| NZ (1) | NZ199340A (sv) |
| PT (1) | PT74190B (sv) |
| SE (1) | SE8107683L (sv) |
-
1981
- 1981-12-11 MA MA19561A patent/MA19357A1/fr unknown
- 1981-12-17 ES ES508103A patent/ES508103A0/es active Granted
- 1981-12-20 AR AR287909A patent/AR229037A1/es active
- 1981-12-21 FI FI814105A patent/FI814105L/fi not_active Application Discontinuation
- 1981-12-21 DE DE19813150550 patent/DE3150550A1/de not_active Withdrawn
- 1981-12-21 SE SE8107683A patent/SE8107683L/sv not_active Application Discontinuation
- 1981-12-21 NO NO814373A patent/NO814373L/no unknown
- 1981-12-21 FR FR8124455A patent/FR2498602A1/fr not_active Withdrawn
- 1981-12-21 NL NL8105749A patent/NL8105749A/nl not_active Application Discontinuation
- 1981-12-21 AU AU78684/81A patent/AU7868481A/en not_active Abandoned
- 1981-12-21 GR GR66870A patent/GR76972B/el unknown
- 1981-12-21 NZ NZ199340A patent/NZ199340A/en unknown
- 1981-12-21 IT IT25728/81A patent/IT1195301B/it active
- 1981-12-22 PT PT74190A patent/PT74190B/pt unknown
- 1981-12-22 LU LU83849A patent/LU83849A1/en unknown
- 1981-12-22 DK DK571581A patent/DK571581A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IT8125728A0 (it) | 1981-12-21 |
| DE3150550A1 (de) | 1982-08-12 |
| AU7868481A (en) | 1982-07-01 |
| GR76972B (sv) | 1984-09-04 |
| AR229037A1 (es) | 1983-05-31 |
| ES8304980A1 (es) | 1983-04-01 |
| FI814105A7 (sv) | 1982-06-24 |
| NO814373L (no) | 1982-06-24 |
| IT1195301B (it) | 1988-10-12 |
| DK571581A (da) | 1982-06-24 |
| NZ199340A (en) | 1984-07-06 |
| NL8105749A (nl) | 1982-07-16 |
| PT74190B (en) | 1983-05-20 |
| FI814105L (fi) | 1982-06-24 |
| FR2498602A1 (fr) | 1982-07-30 |
| SE8107683L (sv) | 1982-06-24 |
| PT74190A (en) | 1982-01-01 |
| MA19357A1 (fr) | 1982-07-01 |
| ES508103A0 (es) | 1983-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1319003B1 (en) | Xanthine phosphodiesterase v inhibitors | |
| US4515795A (en) | Pharmaceutical compositions | |
| US5223504A (en) | Xanthine compounds and compositions, and methods of using them | |
| DE60101158T2 (de) | 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren | |
| JP2613355B2 (ja) | パーキンソン氏病治療剤 | |
| US4576947A (en) | Pharmaceutical compositions | |
| JP2000516223A (ja) | チエノピリミジン類 | |
| JP2000072773A (ja) | プリン誘導体 | |
| JP2005516975A (ja) | ８−ヘテロアリールキサンチンアデノシンａ２ｂ受容体アンタゴニスト | |
| JPH0242079A (ja) | 縮合ピリミジン誘導体およびその製造方法 | |
| JPH054983A (ja) | イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤 | |
| JPH09508127A (ja) | 上皮増殖因子受容体ファミリーのチロシンキナーゼを阻害することができる二環式化合物 | |
| JPH0256484A (ja) | 縮合ピリミジン誘導体およびその製造方法 | |
| KR20010032051A (ko) | 퓨린유도체 및 이를 유효성분으로 함유하는 의약 | |
| HU180219B (en) | Process for producing substituted xantine derivatives and salts | |
| CA2002834C (en) | Cycloalkyl xanthines | |
| CA2612176C (en) | Dihydrothieno[2,3-d]pyramidine-6-carboxylic acid derivatives as pde9 inhibitors | |
| GB2091249A (en) | Xanthine derivatives | |
| US4097482A (en) | 5-O-Cyanobenzyl-4,5,6,7-tetrahydro-thieno 3,2-c!pyridine maleate | |
| ZA200201650B (en) | Selective antagonists of A2B adenosine receptors. | |
| JP5366211B2 (ja) | アルドース還元酵素阻害活性を有する縮合三環化合物 | |
| JP2000501420A (ja) | 新規なトリアゾロプリン類、その調製方法及び医薬組成物としての使用 | |
| EP0330031B1 (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
| LU83849A1 (en) | PROCESS FOR THE PREPARATION OF XANTHINE DERIVATIVES | |
| EP0244352B1 (en) | Pyrido[4,3-d]pyrimidine derivatives |